Abstract
The chemotherapy of primary and secondary neoplasms of the liver has evoked over the past decades passing through phases of single agent systemic treatment, regional infusion chemotherapy, combination chemotherapy and finally continuous regional drug delivering. This latter development has been made possible through the development of a very sophisticated biomedical device: the totally implantable pump. Since it’s introduction for continuous hepatic arterial chemotherapy in 1980 it is estimated that over 5000 implantations have been performed of the Infusaid® pump, suggesting a therapeutic fad in the treatment of liver metastases. Although the Infusaid pump represents a substantial technological advance, it is important to distinguish the device itself, it’s reliability and the role it plays in regional chemotherapy, from the efficacy of the regional approach to metastatic colorectal cancer in the liver. This chapter will mainly focus on this latter complex problem in which the pump is merely a device for the delivery of agents which, like the method itself, will be subject to a critical review of credits and debits.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
De Brauw LM, Van de Velde CJH, Bouwhuis-Hoogerwerf ML, Zwaveling A: Diagnostic evaluation and survival analysis of colorectal cancer patients with liver metastasis. J Surg Oncol 34: 81–86, 1987
Ackerman NB, Lien WM, Kondi ES, Silverman NA: The blood supply of experimental metastasis: I. The distribution of hepatic artery and portal vein blood to ‘small’ and ‘large’ tumors. Surgery 66: 1067–1072, 1969
Strohmeier T, Haugeberg G, Lierse W: Vaskularisation von Lebermetastasen: eine korrosionsanatomische Studie. Acta Anat 12: 172–176, 1986
Ackerman NB: Experimental studies on the role of the portal circulation in hepatic tumor vascularity. Cancer 58: 1653–1657, 1986
Cho KJ, Lunderquist A: Experimental hepatic artery embolization with Gelfoam powder: Microfil perfusion study of the rabbit liver. Invest Radiol 17: 523–527, 1982
Lin G, Lunderquist A, Hägerstrand I, Boijsen E: Postmortem examination of the blood supply and vascular pattern of small liver metastases in man. Surgery 96: 517–526, 1984
Chen HSG, Gross JF: Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treatm Rep 64: 31–40, 1980
Ensminger WD, Rosowsky A, Raso V, et al.: A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2’-deoxyuridine and 5-fluorouracil. Cancer Res 38: 3784–3792, 1982
McDermott BJ, Van den Berg HW, Murphy RF: Non-linear pharmacokinetics for the elimination of 5-fluorouracil after intravenous administration in cancer patients. Cancer Chemother Pharmacol 9: 173–178, 1982
De Bruijn EA, Remeijer L, Tjaden UR, et al.: Non-linear pharmacokinetics of 5-fluorouracil as described by in-vivo behaviour of 5, 6 dihydro-5-fluorouracil. Biochem Pharmacol 35: 2461–2465, 1986
Schein PS: Management of hepatic metastases: A general overview. In: Van de Velde CJH, Sugarbaker PH (eds) Liver Metastasis, Basic aspects, Detection and Management. Martinus Nijhoff Publ, Boston/Dordrecht/Lancaster, 1984, pp 169–177
Mandel HG: The target cell determination of the antitumor actions of 5-FU: Does 5-FU incorporation into RNA play a role? Cancer Treatm Rep 65: 63–71, 1981
Heidelberger C: Pyrimidine and pyrimidine nucleoside antimetabolites. In: Holland JF, Frei E (eds) Cancer Medicine. Philadelphia, Pens., Lea and Febiger, 1973, pp 768–791
Washtien WL, Santi DV: Assay of intracellular free and macromolecular bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil. Cancer Res 38: 3397–3404, 1979
Welch JP, Donaldson GA: Detection and treatment of recurrent cancer of the colon and rectum. Am J Surg 135: 505–511, 1978
Hughes KS, Simon R, Songhorabodi S, et al.: Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence. Surgery 100:278–284, 1986
Jaffe BM, Donegan WL, Watson F, et al.: Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 127: 1–11, 1968
Grage TB, Vassilopoulos PP, Shingleton WW, et al: Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil vs intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: a Central Oncology Group study. Surgery 86: 550–555, 1979
Opfell RW, Bowen J: Regional chemotherapy of liver cancer. In: Bottino JC, Opfell RW, Muggia FM (eds) Liver Cancer. Martinus Nijhoff, Boston, 1985, pp 247–263
Cotino H, Zwaveling A: Treatment of experimental liver tumors by continuous intra-arterial chemotherapy. Eur J Cancer 12: 177–180, 1976
Blackshear PJ: Implantable drug-delivery systems. Scientific American 241: 66–73, 1979
Frei E, Garnick MB, Ensminger WD, et al.: Biochemical pharmacology in medical oncology. Cancer Treatm Rep 65, Suppl. 3: 21–26, 1981
Seifert P, Baker LH, Reed ML, et al.: Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma. Cancer 36:123–128, 1975
Blackshear PJ, Dorman FD, Blackshear PL, etal.: The design and initial testing of an implantable infusion pump. Surg Gynecol Obstet 143: 54–56, 1972
Buchwald H, Grage TB, Vassilopoulos PP, etal.: Intra-arterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer 45: 866–869, 1980
Ensminger W, Niederhuber J, Gyves J, et al.: Effective control of liver metastases from colon cancer with an implanted system for hepatic arterial chemotherapy. Proc Am Soc Clin Oncol (Abstr) 1: 82, 1982
Balch DM, Urist MM, Soong SJ, McGregor M: A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 198: 567–573, 1983
Weiss GR, Garnick MB, Osteen RT, et al.: Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump. J Clin Oncol 1: 337–344, 1983
Schwartz SI, Jones LS, McCune GS: Assessment of treatment of intrahepatic malignancies using chemotherapy via an implantable pump. Ann Surg 201: 560–565, 1985
Cohen AM, Greenfield A, Wood WC, et al.: Treatment of hepatic metastases by transaxillary hepatic artery chemotherapy using an implanted drug pump. Cancer 51: 2013–2019, 1983
Niederhuber E, Ensminger WD, Gyves J, et al.: Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 53: 1336–1343, 1984
Johnson LP, Wasserman PB, Rivkin SE: The implanted pump in metastatic colorectal cancer of the liver. Am J Surg 149: 595–598, 1985
Lahr CJ, Soong SJ, Cloud G, et al.: A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol 1: 720–726, 1983
Kemeny M, Daly J, Oderman P, et al.: Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma. J Clin Oncol 2: 595–600, 1984
Lokich JJ, Kinsella T, Perri J, et al: Concomitant hepatic radiation and intra-arterial fluorinated pyrimidine therapy: Correlation of liver scan, liver function tests, and plasma CEA and tumor response. Cancer 48: 2569–2574, 1981
Van de Velde CJH, Veenhof CHN, Sugarbaker PH: Methodology in the clinical study of heaptic metastases. In: Van de Velde CJH, Sugarbaker PH (eds) Liver Metastasis, Basic aspects, detection and management. Martinus Nijhoff Publ Boston/Dordrecht/Lancaster, 1984, pp 358–375
Kemeny M, Reichman D, Oderman P, et al.: Update of randomized study of intrahepatic vs systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Proc Am Soc Clin Oncol (Abstr) 5: 349, 1986
Sugarbaker PH: Unpublished results, 1987
Niederhuber JE: Arterial chemotherapy for metastatic colorectal cancer in the liver: hepatic tumor study group. In: Abstract-book II Int Conf Adv Reg Cancer Ther, Giessen, W-Germany, 1985, p 23
Shepard KV, Levin B, Karl RC: Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump. J Clin Oncol 3: 161–169, 1985
Kemeny MM, Goldberg D, Beatty, et al.: Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer 57: 492–498, 1986
Hodgson WJB, Friedland M, Mittelman A, et al.: Treatment of colorectal hepatic metastases by intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic disease. Ann Surg 203: 420–425, 1986
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
van de Velde, C.J.H., de Brauw, L.M., Sugarbaker, P.H., Tranberg, KG. (1988). Hepatic arterial infusion chemotherapy: rationale, results, credits and debits. In: Bengmark, S. (eds) Progress in Surgery of the Liver, Pancreas and Biliary System. Developments in Surgery, vol 9. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3349-1_9
Download citation
DOI: https://doi.org/10.1007/978-94-009-3349-1_9
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8004-0
Online ISBN: 978-94-009-3349-1
eBook Packages: Springer Book Archive